Innate Pharma (IPHA) Income Statement & Earnings

1.830
+0.090+5.17%

Close May 29 16:00 ET

1.833
+0.003+0.15%

Post 17:21 ET

171.84MMarket Cap-2.85P/E (TTM)

Innate Pharma (IPHA) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(FY)Dec 31, 2024

(FY)Dec 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

(FY)Dec 31, 2018

(FY)Dec 31, 2017

(FY)Dec 31, 2016

Total revenue

-77.92%2.79M

-75.68%12.62M

4.68%51.9M

309.41%49.58M

-78.43%12.11M

-18.15%56.16M

-14.12%68.61M

144.83%79.89M

-41.90%32.63M

213.64%56.16M

Operating revenue

-81.81%2.29M

-75.79%12.57M

3.37%51.89M

314.51%50.2M

-78.59%12.11M

-17.18%56.57M

-14.00%68.31M

145.53%79.42M

-42.52%32.35M

214.58%56.27M

Cost of revenue

-99.21%337K

42.74M

Gross profit

886.82%79.56M

-118.00%-10.11M

213.64%56.16M

Operating expense

-12.44%56.21M

-0.58%64.2M

-2.17%64.57M

10.12%66.01M

8.83%59.94M

-17.84%55.08M

-9.91%67.04M

149.10%74.41M

-38.52%29.87M

69.42%48.59M

Selling and administrative expenses

-7.83%11M

1.57%11.93M

-18.83%11.75M

-9.49%14.47M

26.00%15.99M

-14.15%12.69M

-18.87%14.78M

-45.91%18.22M

261.07%33.68M

58.71%9.33M

-Selling and marketing expense

----

132.36%1.51M

44.22%649K

56.25%450K

-General and administrative expense

-7.83%11M

1.57%11.93M

-18.83%11.75M

-9.49%14.47M

26.00%15.99M

-14.15%12.69M

-11.55%14.78M

-49.41%16.71M

272.06%33.04M

58.84%8.88M

Research and development costs

-16.08%43.62M

-7.22%51.98M

8.44%56.02M

9.91%51.66M

-5.44%47M

-20.97%49.71M

-9.57%62.9M

2,078.36%69.56M

-93.43%3.19M

62.60%48.63M

Depreciation amortization depletion

----

-84.24%693K

2,177.72%4.4M

48.46%193K

-Depreciation and amortization

----

-84.24%693K

2,177.72%4.4M

48.46%193K

Other operating expenses

460.92%1.59M

108.88%284K

-2,342.75%-3.2M

95.72%-131K

58.24%-3.06M

31.21%-7.32M

24.29%-10.65M

-23.31%-14.06M

-19.26%-11.4M

-32.15%-9.56M

Operating profit

-3.59%-53.43M

-307.10%-51.58M

22.87%-12.67M

65.66%-16.43M

-4,532.53%-47.83M

-31.40%1.08M

-69.43%1.57M

112.87%5.15M

-628.09%-39.98M

170.28%7.57M

Net non-operating interest income expense

-53.07%878K

-26.25%1.87M

883.33%2.54M

1,620.00%258K

-93.27%15K

-84.44%223K

10.40%1.43M

20.07%1.3M

57.58%1.08M

712.50%686K

Non-operating interest income

-45.92%1.32M

-23.29%2.44M

481.87%3.18M

66.97%546K

-42.02%327K

-65.19%564K

2.40%1.62M

26.16%1.58M

--1.25M

----

Non-operating interest expense

-22.26%440K

-11.56%566K

122.22%640K

-7.69%288K

-8.50%312K

67.16%341K

100.00%204K

-9.73%102K

-8.87%113K

-10.79%124K

Total other finance cost

----

-109.34%-17K

203.33%182K

107.41%60K

-2,900.00%-810K

Other net income (expense)

1,352.16%3.37M

-90.94%232K

106.13%2.56M

-1,894.21%-41.81M

209.34%2.33M

-143.86%-2.13M

230.44%4.86M

59.13%-3.73M

-294.60%-9.12M

12.11%4.68M

Gain on sale of security

1,603.45%3.95M

-90.94%232K

418.26%2.56M

-134.55%-805K

209.34%2.33M

-143.86%-2.13M

230.44%4.86M

59.13%-3.73M

-294.60%-9.12M

12.11%4.68M

Special income (charges)

---583K

--0

---41M

--0

----

--0

----

-Less：Restructuring and merger&acquisition

--583K

----

-Less:Impairment of capital assets

--0

--41M

--0

----

--0

----

Income before tax

0.59%-49.18M

-553.51%-49.47M

86.94%-7.57M

-27.47%-57.97M

-5,385.89%-45.48M

-110.54%-829K

189.48%7.87M

105.66%2.72M

-471.04%-48.02M

292.98%12.94M

Income tax

-190.49%-333K

22.26%368K

301K

Net income

0.59%-49.18M

-553.51%-49.47M

86.97%-7.57M

-10.02%-58.1M

17.47%-52.81M

-208.22%-63.98M

-780.85%-20.76M

106.30%3.05M

-482.79%-48.39M

288.49%12.64M

Net income continuous Operations

0.59%-49.18M

-553.51%-49.47M

86.94%-7.57M

-27.47%-57.97M

-5,385.89%-45.48M

-110.54%-829K

158.05%7.87M

106.30%3.05M

-482.79%-48.39M

288.49%12.64M

Net income discontinuous operations

--0

98.21%-131K

88.39%-7.33M

-120.61%-63.16M

---28.63M

----

Minority interest income

Net income attributable to the parent company

0.59%-49.18M

-553.51%-49.47M

86.97%-7.57M

-10.02%-58.1M

17.47%-52.81M

-208.22%-63.98M

-780.85%-20.76M

106.30%3.05M

-482.79%-48.39M

288.49%12.64M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

0.59%-49.18M

-553.51%-49.47M

86.97%-7.57M

-10.02%-58.1M

17.47%-52.81M

-208.22%-63.98M

-780.85%-20.76M

106.30%3.05M

-482.79%-48.39M

288.49%12.64M

Basic earnings per share

9.84%-0.55

-577.78%-0.61

87.67%-0.09

-10.61%-0.73

18.52%-0.66

-161.29%-0.81

-720.00%-0.31

105.62%0.05

-486.96%-0.89

276.92%0.23

Diluted earnings per share

9.84%-0.55

-577.78%-0.61

87.67%-0.09

-10.61%-0.73

18.52%-0.66

-161.29%-0.81

-720.00%-0.31

105.62%0.05

-486.96%-0.89

276.92%0.23

Dividend per share

Currency Unit

EUR

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(FY)Dec 31, 2025	(FY)Dec 31, 2024	(FY)Dec 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019	(FY)Dec 31, 2018	(FY)Dec 31, 2017	(FY)Dec 31, 2016
Total revenue	-77.92%2.79M	-75.68%12.62M	4.68%51.9M	309.41%49.58M	-78.43%12.11M	-18.15%56.16M	-14.12%68.61M	144.83%79.89M	-41.90%32.63M	213.64%56.16M
Operating revenue	-81.81%2.29M	-75.79%12.57M	3.37%51.89M	314.51%50.2M	-78.59%12.11M	-17.18%56.57M	-14.00%68.31M	145.53%79.42M	-42.52%32.35M	214.58%56.27M
Cost of revenue								-99.21%337K	42.74M	0
Gross profit								886.82%79.56M	-118.00%-10.11M	213.64%56.16M
Operating expense	-12.44%56.21M	-0.58%64.2M	-2.17%64.57M	10.12%66.01M	8.83%59.94M	-17.84%55.08M	-9.91%67.04M	149.10%74.41M	-38.52%29.87M	69.42%48.59M
Selling and administrative expenses	-7.83%11M	1.57%11.93M	-18.83%11.75M	-9.49%14.47M	26.00%15.99M	-14.15%12.69M	-18.87%14.78M	-45.91%18.22M	261.07%33.68M	58.71%9.33M
-Selling and marketing expense	----	----	----	----	----	----	----	132.36%1.51M	44.22%649K	56.25%450K
-General and administrative expense	-7.83%11M	1.57%11.93M	-18.83%11.75M	-9.49%14.47M	26.00%15.99M	-14.15%12.69M	-11.55%14.78M	-49.41%16.71M	272.06%33.04M	58.84%8.88M
Research and development costs	-16.08%43.62M	-7.22%51.98M	8.44%56.02M	9.91%51.66M	-5.44%47M	-20.97%49.71M	-9.57%62.9M	2,078.36%69.56M	-93.43%3.19M	62.60%48.63M
Depreciation amortization depletion	----	----	----	----	----	----	----	-84.24%693K	2,177.72%4.4M	48.46%193K
-Depreciation and amortization	----	----	----	----	----	----	----	-84.24%693K	2,177.72%4.4M	48.46%193K
Other operating expenses	460.92%1.59M	108.88%284K	-2,342.75%-3.2M	95.72%-131K	58.24%-3.06M	31.21%-7.32M	24.29%-10.65M	-23.31%-14.06M	-19.26%-11.4M	-32.15%-9.56M
Operating profit	-3.59%-53.43M	-307.10%-51.58M	22.87%-12.67M	65.66%-16.43M	-4,532.53%-47.83M	-31.40%1.08M	-69.43%1.57M	112.87%5.15M	-628.09%-39.98M	170.28%7.57M
Net non-operating interest income expense	-53.07%878K	-26.25%1.87M	883.33%2.54M	1,620.00%258K	-93.27%15K	-84.44%223K	10.40%1.43M	20.07%1.3M	57.58%1.08M	712.50%686K
Non-operating interest income	-45.92%1.32M	-23.29%2.44M	481.87%3.18M	66.97%546K	-42.02%327K	-65.19%564K	2.40%1.62M	26.16%1.58M	--1.25M	----
Non-operating interest expense	-22.26%440K	-11.56%566K	122.22%640K	-7.69%288K	-8.50%312K	67.16%341K	100.00%204K	-9.73%102K	-8.87%113K	-10.79%124K
Total other finance cost	----	----	----	----	----	----	-109.34%-17K	203.33%182K	107.41%60K	-2,900.00%-810K
Other net income (expense)	1,352.16%3.37M	-90.94%232K	106.13%2.56M	-1,894.21%-41.81M	209.34%2.33M	-143.86%-2.13M	230.44%4.86M	59.13%-3.73M	-294.60%-9.12M	12.11%4.68M
Gain on sale of security	1,603.45%3.95M	-90.94%232K	418.26%2.56M	-134.55%-805K	209.34%2.33M	-143.86%-2.13M	230.44%4.86M	59.13%-3.73M	-294.60%-9.12M	12.11%4.68M
Special income (charges)	---583K	--0	--0	---41M	--0	--0	----	--0	----	----
-Less：Restructuring and merger&acquisition	--583K	----	----	----	----	----	----	----	----	----
-Less:Impairment of capital assets	--0	--0	--0	--41M	--0	--0	----	--0	----	----
Income before tax	0.59%-49.18M	-553.51%-49.47M	86.94%-7.57M	-27.47%-57.97M	-5,385.89%-45.48M	-110.54%-829K	189.48%7.87M	105.66%2.72M	-471.04%-48.02M	292.98%12.94M
Income tax	0	0	0	0	0	0	0	-190.49%-333K	22.26%368K	301K
Net income	0.59%-49.18M	-553.51%-49.47M	86.97%-7.57M	-10.02%-58.1M	17.47%-52.81M	-208.22%-63.98M	-780.85%-20.76M	106.30%3.05M	-482.79%-48.39M	288.49%12.64M
Net income continuous Operations	0.59%-49.18M	-553.51%-49.47M	86.94%-7.57M	-27.47%-57.97M	-5,385.89%-45.48M	-110.54%-829K	158.05%7.87M	106.30%3.05M	-482.79%-48.39M	288.49%12.64M
Net income discontinuous operations	--0	--0	--0	98.21%-131K	88.39%-7.33M	-120.61%-63.16M	---28.63M	----	----	----
Minority interest income
Net income attributable to the parent company	0.59%-49.18M	-553.51%-49.47M	86.97%-7.57M	-10.02%-58.1M	17.47%-52.81M	-208.22%-63.98M	-780.85%-20.76M	106.30%3.05M	-482.79%-48.39M	288.49%12.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	0.59%-49.18M	-553.51%-49.47M	86.97%-7.57M	-10.02%-58.1M	17.47%-52.81M	-208.22%-63.98M	-780.85%-20.76M	106.30%3.05M	-482.79%-48.39M	288.49%12.64M
Basic earnings per share	9.84%-0.55	-577.78%-0.61	87.67%-0.09	-10.61%-0.73	18.52%-0.66	-161.29%-0.81	-720.00%-0.31	105.62%0.05	-486.96%-0.89	276.92%0.23
Diluted earnings per share	9.84%-0.55	-577.78%-0.61	87.67%-0.09	-10.61%-0.73	18.52%-0.66	-161.29%-0.81	-720.00%-0.31	105.62%0.05	-486.96%-0.89	276.92%0.23
Dividend per share
Currency Unit	EUR	EUR	EUR	EUR	EUR	EUR	EUR	EUR	EUR	EUR
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion	--	--	--	--	--

On May 29, Eastern Time, Trump held a two-hour meeting in the White House Situation Room but has not yet reached a final decision on negotia Show More

Futubull Options Sir

May 26 18:03

Options Sir on Macro | Big Week Ahead! US-Iran Deal May Materialize + PCE Data Looms—How to Navigate Markets Next?

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.